期刊文献+

维持性血液透析患者血氨基酸谱及营养状况分析 被引量:7

Serum Amino Acid Profile and Nutrition Status in Maintenance Hemodialysis Patients
在线阅读 下载PDF
导出
摘要 目的了解维持性血液透析(MHD)病人的血清游离氨基酸谱及营养状况。方法对49例维持性血液透析病人进行饮食评估;测量身高、体重、三头肌皮褶厚度(TSF)、上臂肌围(MAMC)、体质指数(BMI)、血清总蛋白和白蛋白,检测和分析血清游离氨基酸谱。结果患者平均能量摄入为115.03kJ·kg-1·d~1,蛋白质摄入为1.06g·kg-1·d~2;26.5%的病人BMI<18.5,存在营养不良。以MAMC评估,30.61%的病人存在中重度肌蛋白消耗;以TSF评估,69.38%的病人存在中重度体脂消耗。MHD病人的血清总蛋白和白蛋白水平正常,总氨基酸量、EAA/NEAA、Leu、Ile、。Phe、Val、Lys、Thr、Ser、Ala和Gln水平显著低于正常人(P<0.05,P<0.01),而Asp、Trp、Arg水平则高于正常人(P<0.01)。结论MHD病人存在明显的血清游离氨基酸谱改变,以必需氨基酸水平低下为主,为预防营养不良的进一步发展,应予以合理的营养干预。 Objective To observe the changes of serum free amino acid profile and nutrition status in maintenance hemodialysis (MHD) patients. Methods Forty-nine MHD patients received dietary investigation, and anthropo-metric assessment including height, weight, triceps skinfold (TSF), midarm muscle circumference (MAMC) and body mass index ( BMI) . The serum total protein, albumin and free amino acid profile were also examined. Results The mean energy intake of patients was 115. 03 kJ·kg-1 ·d -l and the mean protein intake was 1. 06 g·kg-1 ·d-1. A total of 26.5% patients had BMI below 18.5. According to TSF and MAMC, the incidence of moderate-to-severe malnutrition was 69. 38% and 30. 61% respectively. The levels of serum total protein and albumin were normal(P < 0.05, P<0. 01). The levels of the total serum amino acids, EAA/NEAA, Leu, Ile, Phe, Val, Lys, Thr, Ser, Ala and Gln in MHD group were lower than the normal. The levels of Asp, Trp and Arg were significantly higher than the normal(P <0. 01). Conclusion There is significant change of serum free amino acid profile in the MHD patients, particularly the essential amino acids. Reasonable nutritional intervention should be done to prevent a further decline in nutritional status.
出处 《上海第二医科大学学报》 CSCD 北大核心 2005年第3期279-281,314,共4页 Acta Universitatis Medicinalis Secondae Shanghai
关键词 病人 维持性血液透析 患者 营养状况分析 中重度 正常人 MHD 血清游离氨基酸 必需氨基酸 血清总蛋白 maintenance hemodialysis serum free amino acid nutritional intervene
  • 相关文献

参考文献9

  • 1姚小丹,刘敏.尸肾移植人类白细胞抗原配型的争议[J].肾脏病与透析肾移植杂志,2001,10(1):94-98. 被引量:6
  • 2Lim VS, Bier DM, Flanigan M J, et al. The effects of hemodialysis on protein metabolism[J]. J Clin Invest,1993,91: 2429-1436.
  • 3Ikizler TA, Flakoll PJ, Parker RA, et al. Amino acid and albumin losses during hemodialysis [ J ]. Kidney Int, 1994,46 (3) : 830 -837.
  • 4Gutierrez A, Alvestrand A, Wahren J, et al. Effect on in vivo contact between blood and dialysis membranes on protein catabolism in humans[J]. Kidney Int,1990,38:487-494.
  • 5Lim VS, Yarasheski KE, Flanigan MJ. The effect of uremia,acidosis and dialysis treatment on protein metabolism:a longitudinal kinetic study [ J ]. Nephrol Dial Fransplant, 1998,13 : 1723 - 1730.
  • 6Neu J, Shenoy V, Chakrabarti R. Gluamine nutrition and metabolism: where do we go from here [J]? FASEB, 1996,10: 829-832.
  • 7Owen WF. Nutritional status and survival in end-stage renal disease patients[ J]. Miner Electrolyte Metab, 1998,24 : 72 - 77.
  • 8Giacomo G. Muscle amino acid metabolism and the control of muscle protein turnover in patients with chronic renal failure[ J]. Nutrition,1999,15(2) : 145 -153.
  • 9Ifudu O. Care of patients undergoing hemodialysis [ J ]. N Eng J Med, 1998, 339:1054 - 1059.

二级参考文献15

  • 1[1]Hariharan S,Johnson CP,Bresnahan BA et al.Improved graft surviaval after renal transplantation in the United States,1988 to 1996.N Engl J Med,2000,342:605
  • 2[2]Nelson G,Anil C.Human leukocyte antigen matching in renal transplantation:an update.Currt Opin Nephrol Hyperten,2000,9:683
  • 3[3]Sumittran-Karruppan S.The clinical importance of choosing the right assay for the detection of HLA-specific donor reactive antibodies.Transplantation,1999,68:502
  • 4[4]Halloran PF,Wadgymar A,Ritchie S et al.The significance of the anti-class I response.I.Clinical and pathologic features of renal transplants with anti-class I-like antibody.Transplantation,1992,53:550
  • 5[5]Torpkov K,Campbell P,Pazderka F et al.Pathologic features of acute renal allograft rejection associated with donor-specific antibody.Analysis using the Banff grading schema.Transplantation,1996,61:1586
  • 6[6]Pascual M,Saidman S,Tolkoff-Rubin N et al.Plasma exchange and tacrolimus-mycophenolate rescue for acute humoral rejection in kidney transplantation.Transplantation,1998,66:1460
  • 7[7]Taylor CJ,Smith SI,Morgan CH et al.Selective ommission of the donor crossmatch before renal transplantation:Efficacy,safety and effects on cold storage time.Transplantation,2000,69:719
  • 8[8]Braun WE.The alloimmunized patient:monitoring and therapeutics.Am J Med Sci,1997,313:279
  • 9[9]Thorogood J,van Houwelingen JC,van Rood JJ et al.Factors contributing to long-term kidney graft survival in Eurotransplant.Transplantation,1992,54:152
  • 10[10]Morris PJ,Johnson RJ,Fuggle SV et al.Analysis of factors that affect outcome of primary cadaveric renal transplantation in the UK.Lancet,1999,354:1147

共引文献5

同被引文献92

引证文献7

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部